Genetic Technology Alert. Alternative Platform for Delivery of RNA Interference Therapeutics; Enhancing Single Cell Platforms for Clinical Genetics and Diagnostics; Molecular Elucidation Of Coenzyme Q 10 in Skin Cells
This issue profiles an alternative platform for delivery of RNAi therapeutics, enhancing single cell platforms for clinical genetics and diagnostics, and molecular elucidation of coenzyme Q 10 in skin cells. Strategic partnership details and some important patents have also been included.
Click headings to expand and collapse
Published: 29 Jun 2012
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..